• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].

作者信息

Fleischmann M, Rödel C

机构信息

Klinik für Strahlentherapie und Onkologie, Universitätsklinikum Frankfurt, Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland.

Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partnerstandort Frankfurt, Frankfurt, Deutschland.

出版信息

Strahlenther Onkol. 2023 Sep;199(9):871-873. doi: 10.1007/s00066-023-02134-1. Epub 2023 Aug 2.

DOI:10.1007/s00066-023-02134-1
PMID:37532957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10449683/
Abstract
摘要

相似文献

1
[Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].[根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌]
Strahlenther Onkol. 2023 Sep;199(9):871-873. doi: 10.1007/s00066-023-02134-1. Epub 2023 Aug 2.
2
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.根治性膀胱切除术与肌肉浸润性膀胱癌的三联疗法：仍需进一步广泛评估——作者回复
Lancet Oncol. 2023 Aug;24(8):e325-e326. doi: 10.1016/S1470-2045(23)00322-4.
3
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis.回复：根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配及加权分析
Eur Urol. 2023 Dec;84(6):602-603. doi: 10.1016/j.eururo.2023.06.026. Epub 2023 Jul 12.
4
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed.根治性膀胱切除术与肌肉浸润性膀胱癌的三联疗法：需要进一步广泛评估。
Lancet Oncol. 2023 Aug;24(8):e324. doi: 10.1016/S1470-2045(23)00321-2.
5
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.当代及新兴的肌层浸润性膀胱癌保膀胱三联疗法。
Hematol Oncol Clin North Am. 2021 Jun;35(3):567-584. doi: 10.1016/j.hoc.2021.02.006. Epub 2021 Apr 15.
6
Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer.针对局部肌肉浸润性膀胱癌中三模态治疗广泛应用的障碍。
Urol Oncol. 2023 Jan;41(1):35-38. doi: 10.1016/j.urolonc.2020.10.005. Epub 2020 Nov 3.
7
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.回复：亚历山大·R·兹洛塔、莱斯利·K·巴拉斯、安杰伊·涅米尔科等人。根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配和加权分析。《柳叶刀·肿瘤学》2023年；24卷：669 - 81页。
Eur Urol. 2024 Jan;85(1):e24. doi: 10.1016/j.eururo.2023.07.019. Epub 2023 Aug 31.
8
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.根治性膀胱切除术或三联疗法治疗肌层浸润性膀胱癌：一项探索患者在做出治疗选择时的优先事项和咨询需求的定性研究。
BMC Cancer. 2024 Jan 31;24(1):160. doi: 10.1186/s12885-024-11927-1.
9
Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.选择性膀胱保存以达到治愈肌层浸润性膀胱癌的目的：当代综述。
Int J Urol. 2012 May;19(5):388-401. doi: 10.1111/j.1442-2042.2012.02974.x. Epub 2012 Mar 12.
10
Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.膀胱癌保留膀胱的三联疗法治疗肌层浸润性膀胱癌。
Curr Oncol Rep. 2018 Jun 30;20(9):66. doi: 10.1007/s11912-018-0711-0.

本文引用的文献

1
Image-guided Adaptive Radiotherapy for Bladder Cancer.膀胱癌的图像引导自适应放疗。
Clin Oncol (R Coll Radiol). 2021 Jun;33(6):350-368. doi: 10.1016/j.clon.2021.03.023.
2
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial.BC2001 期随机对照临床试验中接受放化疗治疗的肌肉浸润性膀胱癌患者的患者报告生存质量结局。
Eur Urol. 2020 Feb;77(2):260-268. doi: 10.1016/j.eururo.2019.11.001. Epub 2019 Dec 13.
3
Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.局部肌层浸润性膀胱癌行三联疗法与根治性膀胱切除术的疗效比较。
Eur Urol. 2017 Oct;72(4):483-487. doi: 10.1016/j.eururo.2017.03.038. Epub 2017 Apr 12.
4
Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.根治性膀胱切除术与肌肉浸润性膀胱癌综合治疗的比较：一项系统评价和荟萃分析。
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1002-1020. doi: 10.1016/j.ijrobp.2016.11.056. Epub 2016 Dec 13.
5
Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed.保留膀胱（选择性膀胱保留术而非根治性切除术）的生死抉择：关于“保留膀胱”试验终止原因的思考
BJU Int. 2010 Sep;106(6):753-5. doi: 10.1111/j.1464-410X.2010.09537.x. Epub 2010 Jul 26.
6
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.浸润性膀胱癌患者膀胱保留治疗后的晚期盆腔毒性：放射治疗肿瘤学组89-03、95-06、97-06、99-06研究
J Clin Oncol. 2009 Sep 1;27(25):4055-61. doi: 10.1200/JCO.2008.19.5776. Epub 2009 Jul 27.